Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 May;69(5):833–839. doi: 10.1038/bjc.1994.162

Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative.

B A Allison 1, P H Pritchard 1, J G Levy 1
PMCID: PMC1968896  PMID: 8180011

Abstract

Plasma lipoproteins, such as low-density lipoprotein (LDL), have been proposed to enhance the delivery of hydrophobic photosensitisers to malignant tissue since tumour cells have been shown to have increased numbers of LDL receptors. We have investigated the role of this receptor in the cellular accumulation of the photosensitiser benzoporphyrin derivative (BPD). We observed that: (1) [14C]BPD-LDL accumulation by LDL receptor-negative fibroblast cell lines was insignificant compared with normal cell lines; (2) there was no evidence that BPD dissociated from LDL during incubation with the cells; and (3) chemical acetylation of LDL markedly decreased the uptake of [14C]BPD-LDL. We conclude, therefore, that virtually all of the photosensitiser accumulated by the cells was due to specific binding and internalisation via the LDL receptor. Subsequent in vivo studies in M-1 (methylcholanthrene-induced rhabdomyosarcoma) tumour-bearing DBA/2J mice showed that tumour accumulation of BPD associated with native LDL was significantly (P < 0.01) enhanced over that of acetyl-LDL-associated BPD. These results indicate that the LDL receptor is responsible for the accumulation of LDL-associated BPD both in vitro and in vivo. Thus, utilisation of this delivery system may provide for improvements in photodynamic therapy in clinical practice.

Full text

PDF
833

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison B. A., Pritchard P. H., Richter A. M., Levy J. G. The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution. Photochem Photobiol. 1990 Sep;52(3):501–507. doi: 10.1111/j.1751-1097.1990.tb01792.x. [DOI] [PubMed] [Google Scholar]
  2. Allison B. A., Waterfield E., Richter A. M., Levy J. G. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative. Photochem Photobiol. 1991 Nov;54(5):709–715. doi: 10.1111/j.1751-1097.1991.tb02079.x. [DOI] [PubMed] [Google Scholar]
  3. Attie A. D., Pittman R. C., Steinberg D. Hepatic catabolism of low density lipoprotein: mechanisms and metabolic consequences. Hepatology. 1982 Mar-Apr;2(2):269–281. doi: 10.1002/hep.1840020215. [DOI] [PubMed] [Google Scholar]
  4. Barel A., Jori G., Perin A., Romandini P., Pagnan A., Biffanti S. Role of high-, low- and very low-density lipoproteins in the transport and tumor-delivery of hematoporphyrin in vivo. Cancer Lett. 1986 Aug;32(2):145–150. doi: 10.1016/0304-3835(86)90112-6. [DOI] [PubMed] [Google Scholar]
  5. Basu S. K., Goldstein J. L., Anderson G. W., Brown M. S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3178–3182. doi: 10.1073/pnas.73.9.3178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Candide C., Morlière P., Mazière J. C., Goldstein S., Santus R., Dubertret L., Reyftmann J. P., Polonovski J. In vitro interaction of the photoactive anticancer porphyrin derivative photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts. FEBS Lett. 1986 Oct 20;207(1):133–138. doi: 10.1016/0014-5793(86)80026-6. [DOI] [PubMed] [Google Scholar]
  7. Dougherty T. J., Cooper M. T., Mang T. S. Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg Med. 1990;10(5):485–488. doi: 10.1002/lsm.1900100514. [DOI] [PubMed] [Google Scholar]
  8. Dougherty T. J. Studies on the structure of porphyrins contained in Photofrin II. Photochem Photobiol. 1987 Nov;46(5):569–573. doi: 10.1111/j.1751-1097.1987.tb04815.x. [DOI] [PubMed] [Google Scholar]
  9. Gal D., MacDonald P. C., Porter J. C., Simpson E. R. Cholesterol metabolism in cancer cells in monolayer culture. III. Low-density lipoprotein metabolism. Int J Cancer. 1981 Sep 15;28(3):315–319. doi: 10.1002/ijc.2910280310. [DOI] [PubMed] [Google Scholar]
  10. Goldstein J. L., Basu S. K., Brown M. S. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 1983;98:241–260. doi: 10.1016/0076-6879(83)98152-1. [DOI] [PubMed] [Google Scholar]
  11. Goldstein J. L., Brown M. S. Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J Biol Chem. 1974 Aug 25;249(16):5153–5162. [PubMed] [Google Scholar]
  12. Goldstein J. L., Ho Y. K., Basu S. K., Brown M. S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979 Jan;76(1):333–337. doi: 10.1073/pnas.76.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gomer C. J. Photodynamic therapy in the treatment of malignancies. Semin Hematol. 1989 Jan;26(1):27–34. [PubMed] [Google Scholar]
  14. Gotto A. M., Jr, Pownall H. J., Havel R. J. Introduction to the plasma lipoproteins. Methods Enzymol. 1986;128:3–41. doi: 10.1016/0076-6879(86)28061-1. [DOI] [PubMed] [Google Scholar]
  15. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Habeeb A. F. Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal Biochem. 1966 Mar;14(3):328–336. doi: 10.1016/0003-2697(66)90275-2. [DOI] [PubMed] [Google Scholar]
  17. Haberland M. E., Olch C. L., Folgelman A. M. Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J Biol Chem. 1984 Sep 25;259(18):11305–11311. [PubMed] [Google Scholar]
  18. Henderson B. W., Dougherty T. J. How does photodynamic therapy work? Photochem Photobiol. 1992 Jan;55(1):145–157. doi: 10.1111/j.1751-1097.1992.tb04222.x. [DOI] [PubMed] [Google Scholar]
  19. Jori G., Beltramini M., Reddi E., Salvato B., Pagnan A., Ziron L., Tomio L., Tsanov T. Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. Cancer Lett. 1984 Oct;24(3):291–297. doi: 10.1016/0304-3835(84)90025-9. [DOI] [PubMed] [Google Scholar]
  20. Jori G. In vivo transport and pharmacokinetic behavior of tumour photosensitizers. Ciba Found Symp. 1989;146:78–94. doi: 10.1002/9780470513842.ch6. [DOI] [PubMed] [Google Scholar]
  21. Kessel D. Porphyrin-lipoprotein association as a factor in porphyrin localization. Cancer Lett. 1986 Nov;33(2):183–188. doi: 10.1016/0304-3835(86)90023-6. [DOI] [PubMed] [Google Scholar]
  22. Kessel D., Thompson P., Musselman B., Chang C. K. Chemistry of hematoporphyrin-derived photosensitizers. Photochem Photobiol. 1987 Nov;46(5):563–568. doi: 10.1111/j.1751-1097.1987.tb04814.x. [DOI] [PubMed] [Google Scholar]
  23. Kongshaug M., Moan J., Brown S. B. The distribution of porphyrins with different tumour localising ability among human plasma proteins. Br J Cancer. 1989 Feb;59(2):184–188. doi: 10.1038/bjc.1989.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Korbelik M., Hung J., Lam S., Palcic B. The effects of low density lipoproteins on uptake of Photofrin II. Photochem Photobiol. 1990 Feb;51(2):191–196. doi: 10.1111/j.1751-1097.1990.tb01702.x. [DOI] [PubMed] [Google Scholar]
  25. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  26. Manyak M. J., Russo A., Smith P. D., Glatstein E. Photodynamic therapy. J Clin Oncol. 1988 Feb;6(2):380–391. doi: 10.1200/JCO.1988.6.2.380. [DOI] [PubMed] [Google Scholar]
  27. Maziere J. C., Santus R., Morliere P., Reyftmann J. P., Candide C., Mora L., Salmon S., Maziere C., Gatt S., Dubertret L. Cellular uptake and photosensitizing properties of anticancer porphyrins in cell membranes and low and high density lipoproteins. J Photochem Photobiol B. 1990 Jun;6(1-2):61–68. doi: 10.1016/1011-1344(90)85074-7. [DOI] [PubMed] [Google Scholar]
  28. Mazière J. C., Morlière P., Santus R. The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. J Photochem Photobiol B. 1991 Mar;8(4):351–360. doi: 10.1016/1011-1344(91)80111-t. [DOI] [PubMed] [Google Scholar]
  29. McFARLANE A. S. Efficient trace-labelling of proteins with iodine. Nature. 1958 Jul 5;182(4627):53–53. doi: 10.1038/182053a0. [DOI] [PubMed] [Google Scholar]
  30. Moan J., Berg K. Photochemotherapy of cancer: experimental research. Photochem Photobiol. 1992 Jun;55(6):931–948. doi: 10.1111/j.1751-1097.1992.tb08541.x. [DOI] [PubMed] [Google Scholar]
  31. Noble R. P. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968 Nov;9(6):693–700. [PubMed] [Google Scholar]
  32. Norata G., Canti G., Ricci L., Nicolin A., Trezzi E., Catapano A. L. In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice. Cancer Lett. 1984 Dec;25(2):203–208. doi: 10.1016/s0304-3835(84)80046-4. [DOI] [PubMed] [Google Scholar]
  33. Richter A. M., Cerruti-Sola S., Sternberg E. D., Dolphin D., Levy J. G. Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. J Photochem Photobiol B. 1990 Apr 15;5(2):231–244. doi: 10.1016/1011-1344(90)80008-l. [DOI] [PubMed] [Google Scholar]
  34. Richter A. M., Kelly B., Chow J., Liu D. J., Towers G. H., Dolphin D., Levy J. G. Preliminary studies on a more effective phototoxic agent than hematoporphyrin. J Natl Cancer Inst. 1987 Dec;79(6):1327–1332. [PubMed] [Google Scholar]
  35. Richter A. M., Waterfield E., Jain A. K., Allison B., Sternberg E. D., Dolphin D., Levy J. G. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model. Br J Cancer. 1991 Jan;63(1):87–93. doi: 10.1038/bjc.1991.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Via D. P., Kempner E. S., Pons L., Fanslow A. E., Vignale S., Smith L. C., Gotto A. M., Jr, Dresel H. A. Mouse macrophage receptor for acetylated low density lipoprotein: demonstration of a fully functional subunit in the membrane and with purified receptor. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6780–6784. doi: 10.1073/pnas.89.15.6780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Vitols S., Gahrton G., Ost A., Peterson C. Elevated low density lipoprotein receptor activity in leukemic cells with monocytic differentiation. Blood. 1984 May;63(5):1186–1193. [PubMed] [Google Scholar]
  38. Weishaupt K. R., Gomer C. J., Dougherty T. J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976 Jul;36(7 Pt 1):2326–2329. [PubMed] [Google Scholar]
  39. Zhou C. N., Milanesi C., Jori G. An ultrastructural comparative evaluation of tumors photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins. Photochem Photobiol. 1988 Oct;48(4):487–492. doi: 10.1111/j.1751-1097.1988.tb02850.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES